Virilizing ovarian tumor is a rare endocrine disorder characterized by the formation of malignant or benign tumors that secrete androgens, male sex hormones. These tumors can cause various symptoms related to virilization, including changes in the menstrual cycle, acne, hirsutism (excessive hair growth in women), and other manifestations associated with increased androgen levels in the body. The classification of virilizing tumors includes many subtypes that differ in their morphology and degree of malignancy, which determines the treatment tactics and prognosis for patients. The importance of understanding this condition is associated not only with its clinical manifestations, but also with the impact on the quality of life of patients, which requires an integrated approach to diagnosis and therapy.
History of the disease and interesting historical facts
Virilizing ovarian tumors were first described in the late 19th century, when scientists began to study the effects of hormones on the development of various diseases. One of the earliest references was a paper published in 1890, when doctors began to associate the appearance of virilization symptoms in women with the presence of ovarian tumors. Since then, medicine has made significant progress in understanding the pathogenesis and clinical picture of this disease. In the 1970s, it was established that virilizing ovarian tumors are most often associated with ovarian stromal tumors, as well as with specific types of granulosa cell and thecal tumors. Interestingly, not only medical but also social reactions to this disease have been recorded in culture, highlighting its impact on the perception of femininity and health.
Epidemiology
Virilizing ovarian tumors are a relatively rare disease. According to various sources, their incidence varies from 0.2 to 1.5 cases per 100,000 women per year. Studies show that these tumors account for only 0.1-0.5% of all ovarian tumors. They are most common in women aged 30 to 50 years, although cases in younger patients are possible. Data on the incidence in older women are less common, which may be due to the fact that ongoing problems with diagnosis and different clinical presentation at a later age obscure the likelihood of detecting virilizing tumors. Epidemiological studies also highlight the high level of diagnostic errors and late diagnosis in various clinical settings, which makes timely referral to specialists important.
Genetic predisposition to this disease
Research indicates a certain genetic predisposition to the development of virilizing ovarian tumors. In particular, family members with various forms of endocrine or gynecological diseases have a high chance of developing the corresponding tumors. Multiple cases of mutations in genes responsible for the control of androgen secretion and steroid synthesis are characterized, including:
- CYP17A1 gene involved in steroid metabolism;
- AR (androgen receptor) gene, associated with androgen transpox;
- Mutations in the KRAS and NRAS genes.
These mutations may affect not only the frequency of the disease, but also its manifestations and the severity of symptoms. The data obtained require further large-scale study to develop genetic counseling and predictive therapy programs.
Risk factors for the development of this disease
Research shows that several physical and chemical risk factors may predispose to the development of virilizing ovarian tumors:
- Long-term use of certain hormonal drugs, such as progestogens;
- The presence of polycystic ovary disease (PCOS), which is associated with hyperandrogenism;
- Elevated levels of testosterone and other androgens in the blood;
- Heredity and the presence of tumors in close relatives;
- Environmental factors such as exposure to certain chemical carcinogens.
Attention to these factors can help in primary prevention and timely diagnosis, especially among risk groups.
Diagnosis of this disease
Diagnosis of virilizing ovarian tumors is based on a carefully collected anamnesis, clinical examination and comprehensive laboratory tests. The main symptoms to pay attention to are:
- Regular menstrual irregularities;
- Excessive hair growth (hirsutism);
- Skin changes such as acne or oily skin;
- Breast reduction and increased hair growth on the chest and face;
- Psycho-emotional changes – irritability, anxiety and depression.
To confirm the diagnosis, a number of laboratory tests are indicated, including determination of testosterone, dehydroepiandrosterone and a number of other androgens. Radiological examination, such as ultrasound examination of the pelvic organs and magnetic resonance imaging (MRI), play an important role in visualizing the neoplasm and assessing its size and structure. Laparoscopy with subsequent biopsy, if necessary, can also be used.
Treatment
Treatment of virilizing ovarian tumors can range from observation for small benign tumors to radical surgery for malignant forms. Surgical treatment is the main method, including:
- Removal of the tumor followed by histological examination;
- Oophorectomy (removal of the ovary) in the presence of large and suspicious formations;
- Salpingectomy (removal of the tube) in case of spread of the process.
Various pharmacological agents are used as adjuvant therapy, including antiandrogen agents such as spironolactone and agents to normalize hormonal levels. Endocrinologists may also prescribe contraceptives to regulate the menstrual cycle and reduce androgens.
List of medications used to treat this disease
Some of the commonly used medications to treat virilizing ovarian tumors include:
- Spironolactone;
- Dexamethasone;
- Simvastatin;
- Clomiphene;
- Low androgen oral contraceptives.
The choice of a specific drug depends on the clinical situation and the patient’s health condition, which requires an individual approach.
Disease monitoring
Monitoring of patients with virilizing ovarian tumors includes regular check-ups and laboratory tests. The main stages of monitoring are:
- Daily monitoring of androgen levels;
- Periodic ultrasound to assess the condition of the ovaries;
- Psychological support to address problems related to disease symptoms.
The prognosis depends largely on the type of tumor (benign or malignant) and the stage of the disease at diagnosis. Possible complications include the development of erosions, blockage of the tubes and recurrence of the disease, requiring repeated testing and treatment.
Age-related features of the disease
Virilizing tumors have different manifestations depending on the age of the patient. In women of reproductive age, symptoms may be more pronounced, including obvious signs of hirsutism and menstrual irregularities. In older women, the disease may manifest itself less clearly and go unnoticed due to the presence of concomitant menstrual irregularities or other gynecological diseases. Adolescents with precocious puberty may also have early signs of virilization, and early diagnosis is important to prevent further problems.
Questions and Answers
- What is virilizing ovarian tumor? It is a tumor that produces androgens and causes symptoms of increased virilization in women.
- What are the main symptoms of this disease? The main symptoms include hirsutism, acne, menstrual irregularities and changes in skin condition.
- What diagnostic methods are used? Diagnosis involves ultrasound, laboratory tests for androgen levels, and, in some cases, biopsy.
- What treatment is prescribed for virilizing tumors? Treatment may include surgical removal of the tumor and drug therapy to normalize hormone levels.
- What is the prognosis for this disease? The prognosis depends on the type of tumor (benign or malignant) and the degree of symptom progression; early detection increases the chances of successful treatment.
